+3 | The top 3 med-tech stories for January 30, 2012.

January 30, 2012 by MassDevice staff

FDA staffers sue for unlawful snooping, the breast implant scare spreads to Germany and Medtronic closes the $478 million sale of Physio-Control to Bain Capital.

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you're still in the know with MassDevice +3.

3. Medtronic closes $478M Physio-Control sale to Bain Capital

Medtronic logo

Medtronic, Inc. (NYSE:MDT) today closed the sale of its Physio-Control defibrillator business to Bain Capital for $478 million in cash.

Read more

Sign up to get our free newsletters delivered straight to your inbox

2. Breast implant scare spreads to Germany

Breast implants

Coming on the heels of the French breast implant controversy, a senior manager at Nuffield Health hospital in Germany warned the country's doctors to avoid a second type of breast implant called Silimed.

Read more